Opsens Inc T.OPS

TAVR procedure potential...

[bossu]

Opsens to be a take over target not long after FDA approval...

The TAVR procedure is on the rise, driven by an aging of the population and recent studies that demonstrate its benefits to patients of all conditions. The TAVR market is currently estimated at $5-billion (U.S.) and is expected to reach $8-billion (U.S.) by 2025.

[Dogsbreakfast4U]

Edwards Lifescience per example could be interested in Opsens Medical but couldn't care less about Opsens Solutions which is why I doubt Opsens the company will be a take over target. 

[jelliedeeel]

Dogs, either you're short and a bit worried so you try to keep the stock down or you didn't do your research properly ...or both. Opsens reorganised in 2015 to seperate physically and legally it's medical operations from Opsens Solutions. So if one wants to take over solely the medical side of the company, that would be quite simple. And even if it would be complicated, not a big

[jelliedeeel]

Here's the press release dating back to September 3rd 2015 relating to the corporate restructuring I was referring to in my previous post: https://opsens.com/2015/opsens-announces-a-reorganization-of-its-corporate-structure/